Skip to main content

Table 4 Stratified analyses by acute kidney injury on pharmacokinetics of vancomycin

From: Association between vancomycin pharmacokinetic/pharmacodynamic parameters, patient characteristics, and mortality in patients with bacteremia caused by vancomycin-susceptible Enterococcus faecium: a single-center retrospective study

 

Characteristic

30-day all-cause mortality group

Survival group

P-value

Acute kidney injury (+)

Number of patients

5

6

Vancomycin trough concentration (μg/mL)a

26 (22.3–33.2)

12.8 (9.1–30.5)

0.20 i)

Vancomycin AUC24 (μg/mL·h)a

859 (393–971)

794 (486–1052)

0.86 i)

Vancomycin AUC24/MIC ratioa

859 (427–971)

809 (459–1409)

0.86 i)

Number of cases with failure to achieve a vancomycin AUC24/MIC ratio ≤ 389

1

0

0.45 ii)

Acute kidney injury (−)

Number of patients

7

27

Vancomycin trough concentration (μg/mL)a

15.0 (12.7–21.4)

14.6 (9.3–18.2)

0.30 i)

Vancomycin AUC24 (μg/mL·h)a

498 (354–765)

645 (417–853)

0.48 i)

Vancomycin AUC24/MIC ratioa

725 (277–1531)

707 (417–1319)

0.75 i)

Number of cases with failure to achieve a vancomycin AUC24/MIC ratio ≤ 389

2

5

0.61 ii)

  1. AUC24 estimated area under the curve from 0 to 24 h, MIC minimum inhibitory concentration
  2. i) Mann-Whitney U test, ii) Fisher’s exact test
  3. aExpressed as medians and interquartile ranges (IQR)
  4. The P-value was calculated by processing the comparison between the 30-day all-cause mortality group and the survival group by an appropriate statistical analysis